Next Capital Management LLC Amgen Inc Transaction History

Next Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $25,921 - $33,318	-137 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$174.11 - $208.62 $17,585 - $21,070	-101 Reduced 42.44%	137 $27,000
Q2 2019 Aug 02, 2019	BUY	$166.7 - $195.41 $11,835 - $13,874	71 Added 42.51%	238 $44,000
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $29,792 - $34,777	167 New	167 $33,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Next Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Next Capital Management LLC with notifications on news.